TNDM - タンデム・ダイアベティス・ケア (Tandem Diabetes Care Inc.) タンデム・ダイアベティス・ケア

 TNDMのチャート


 TNDMの企業情報

symbol TNDM
会社名 Tandem Diabetes Care Inc (タンデム・ダイアベティス・ケア)
分野(sector) Health Care   ヘルスケア
産業(industry) Medical/Dental Instruments  
業種 医療機器_医療用品_ディストリビュ―タ―   医療関連(Health Care)
概要 事業概要 タンデム・ダイアベティス・ケア(Tandem Diabetes Care Inc.)はインスリン依存性糖尿病を有する人々に製品の設計・開発・商業化を提供する医療機器会社である。同社は技術プラットフォーム及び消費者中心のアプローチに基づいて同社の代表的製品である「t:slim」インスリン送達システムまたは「t:slim」を設計・商業化する。同社の技術プラットフォームはシリンジとプランジャー機構に依頼するよりも、ポンプのカートリッジ内で柔軟性のあるバッグからインスリンを描く小型化ポンプ機構であるマイクロ送達技術を特徴とする。同社はまた所望のユーザーに同社の機器を最適化しようとする同社の設計・開発プロセスに人的要因の研究を応用し、これによってユーザーが所望の環境で機器を正常に操作することを可能にする。   タンデム・ダイアベティス・ケアは米国の医療機器メ―カ―。主に、インスリン依存性糖尿病患者向けの製品の設計、開発、商業化に従事。主力製品は、「t: slim」インスリン・デリバリ―・システム。技術プラットフォ―ムには、特許を取得している小型ポンプメカニズムのマイクロ・デリバリ―・テクノロジ―がある。本社はカリフォルニア州。   Tandem Diabetes Care, Inc. is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. The Company takes an innovative, user-centric approach to the design, development and commercialization of products for people with diabetes who use insulin. Tandem's flagship product, the t:slim X2™ insulin pump, is capable of remote software updates using a personal computer and features integrated continuous glucose monitoring. Tandem is based in San Diego, California.
本社所在地 11045 Roselle Street San Diego CA 92121 USA
代表者氏名 Dick P. Allen ディックP.アレン
代表者役職名 Independent Chairman of the Board
電話番号 +1 858-366-6900
設立年月日 38718
市場名 NASDAQ National Market System
ipoyear 2013年
従業員数
url www.tandemdiabetes.com
nasdaq_url https://www.nasdaq.com/symbol/tndm
adr_tso
EBITDA EBITDA(百万ドル) -45.48400
終値(lastsale) 34.725
時価総額(marketcap) 1987146597.9
時価総額 時価総額(百万ドル) 1946.893
売上高 売上高(百万ドル) 128.70100
企業価値(EV) 企業価値(EV)(百万ドル) 1937.488
当期純利益 当期純利益(百万ドル) -171.09300
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Tandem Diabetes Care Inc revenues increased 52% to $61.4M. Net loss increased from $45.6M to $92.1M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Research and development - Balancing val increase of 31% to $11.9M (expense) Other Selling general and administ. increase of 5% to $40.5M (expense).

 TNDMのテクニカル分析


 TNDMのニュース

   Artificial Pancreas Devices Systems Market 2021: Detailed Analysis of Current Industry Figures with Forecasts Growth By 2028| Medtronic, Bigfoot Biomedical, Beta Bionics, Admetsys, Insulet, Tandem Diabetes Care, Defymed, and Others.  2021/09/01 10:27:44 OpenPR
The global artificial pancreas device systems market exhibited strong growth during 2015-2021. Looking forward, IMARC Group expects the market to grow at a CAGR of 12% during 2021-2028. Artificial pancreas device system are the devices that closely copy the glucose regulating function
   Digital Diabetes Device Market Size 2021 by Product Sales, Revenue, Price, Market Share, Growth Opportunity and Forecast to 2027 Research Report I Top key players-Lifescan, Roche, Medtronic, Ascensia Diabetes Care, TANDEM Diabetes Care, DEXCOM, Social D  2021/08/30 11:15:37 OpenPR
Digital diabetes devices are the executives'' arrangements are cell phone associated diabetes the board gadgets and programming stages utilized by patients experiencing Type 1, Type 2, and gestational diabetes. Clinical experts likewise utilize these answers to oversee diabetes. Get sample copy
   Beyond Type 1 Named an Official Charity Partner of the 2021 TCS New York City Marathon  2021/08/25 19:00:00 Benzinga
SAN CARLOS, Calif., Aug. 25, 2021 /PRNewswire/ -- Global diabetes nonprofit Beyond Type 1 was named an Official Charity Partner for the 2021 TCS New York City Marathon, taking place on November 7 . This year serves as the 50th celebratory running of the marathon. Beyond Type 1 will be among the more than 400 official charity partners providing thousands of runners the opportunity to run in the world''s most popular marathon. Presented by Dexcom and Tandem Diabetes Care , this year''s Beyond Type Run Team is made up of 50 runners living with Type 1 diabetes (T1D) from 23 states and five countries. These individuals are raising awareness and funds for Type 1 diabetes as ambassadors for Beyond Type 1, showcasing how they live beyond their diagnoses and supporting crucial efforts and programs for others affected by this condition. "We''re thrilled to get the chance to assemble another incredible and inspiring team showing people with diabetes everywhere that anything is possible with this condition," said Beyond Type 1 CEO Thom Scher . "We''re grateful for support from Dexcom and Tandem Diabetes Care and the opportunity to connect and inspire community members through Beyond Type Run." Beyond Type 1 has taken three prior teams to the TCS New York City Marathon in 2017, 2018 and 2019 with a goal of inspiring individuals affected by diabetes all over the world.
   Consonance Capital Management LP Buys Tandem Diabetes Care Inc, Globus Medical Inc, Protagonist ...  2021/08/18 16:38:17 GuruFocus
Related Stocks: GMED , PTGX , LEGN , VSTM , TNDM , SRPT , CHFW.U , SLN , JYAC , RACB , MGNX , MRTX , TPTX , ARVN , IOVA , ATRA ,
   Algert Coldiron Investors Llc Buys Herbalife Nutrition, Carter''s Inc, Tandem Diabetes Care Inc, ...  2021/08/16 23:38:16 GuruFocus
Related Stocks: HLF , TNDM , AMZN , UNVR , SLGN , TNET , CRI , BA , EQIX , CPRT , GOOG , ANTM , WFC , V , INTC , VLO , ROST , BWXT ,
   The Daily Biotech Pulse: Sanofi, GSK Begin Phase 1/2 Coronavirus Vaccine Study, Fulgent Strikes COVID-19 Testing Deal, New Data From Novavax  2020/09/03 11:55:02 Benzinga
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Acutus Medical Inc (NASDAQ: AFIB ) Akouos Inc (NASDAQ: AKUS ) Avid Bioservices Inc (NASDAQ: CDMO ) ( reacted to strong quarterly results) BioLife Solutions Inc (NASDAQ: BLFS ) Corcept Therapeutics Incorporated (NASDAQ: CORT ) Edwards Lifesciences Corp (NYSE: EW ) Evogene Ltd (NASDAQ: EVGN ) Fortress Biotech (NASDAQ: FBIO ) Generation Bio Co (NASDAQ: GBIO ) Immunovant Inc (NASDAQ: IMVT ) (priced its 5.27-million-share common stock offering at $33 per share) Inspire Medical Systems Inc (NYSE: INSP ) Intuitive Surgical, Inc. (NASDAQ: ISRG ) Silk Road Medical Inc (NASDAQ: SILK ) Shockwave Medical Inc (NASDAQ: SWAV ) Tandem Diabetes Care Inc (NASDAQ: TNDM ) TG Therapeutics Inc common stock (NASDAQ: TGTX ) Twist Bioscience Corp (NASDAQ: TWST ) (announced potent SARS-CoV-2 neutralizing data from COVID-19 therapeutic antibody program) West Pharmaceutical Services Inc. (NYSE: WST ) Zoetis Inc (NYSE: ZTS ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Sept. 2) Acorda Therapeutics Inc (NASDAQ: ACOR ) ADiTx Therapeutics Inc (NASDAQ: ADTX ) (priced a $9.6-million follow-on offering) China SXT Pharmaceuticals Inc (NASDAQ: SXTC ) Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC ) Entera Bio Ltd (NASDAQ: ENTX ) Eyepoint Pharmaceuticals Inc (NASDAQ: EYPT ) Gritstone Oncology Inc (NASDAQ: GRTS ) Happiness Biotech Group Ltd (NASDAQ: HAPP ) Histogen Inc (NASDAQ: HSTO ) Interpace Biosciences Inc (NASDAQ: IDXG ) Iterum Therapeutics PLC (NASDAQ: ITRM ) NanoVibronix Inc (NASDAQ: NAOV ) Neurobo Pharmaceuticals Inc (NASDAQ: NRBO ) Nkarta Inc (NASDAQ: NKTX ) Oncternal Therapeutics Inc (NASDAQ: ONCT ) Psychemedics Corp. (NASDAQ: PMD ) Rockwell Medical Inc (NASDAQ: RMTI ) Sun BioPharma, Inc. (NASDAQ: SNBP ) Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS ) Stocks In Focus Sutro To Present Positive Phase 1 Ovarian Cancer Data In an abstract submitted to the International Gynecologic Cancer Society …
   Tandem Diabetes Care Announces Upcoming Webcast Conference Presentations  2020/09/02 20:05:00 Business Wire
SAN DIEGO--(BUSINESS WIRE)---- $TNDM #TNDM--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that John Sheridan, president and chief executive officer, will present a company update at the following virtual investor conferences: Wells Fargo 2020 Healthcare Conference on Wednesday, September 9, 2020 at 12:00pm Eastern Time (9:00am Pacific Time), Morgan Stanley 18th Annual Global Healthcare Conference on Wednesday, September 16, 2020 at 11:45a
   The Daily Biotech Pulse: Amarin's Vascepa Appeal Hearing, Avid Bioservices' Strong Q1, A Life Sciences Blank Check IPO  2020/09/02 11:25:11 Benzinga
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1) 10X Genomics Inc (NASDAQ: TXG ) Acutus Medical Inc (NASDAQ: AFIB ) Akouos Inc (NASDAQ: AKUS ) Catalent Inc (NYSE: CTLT ) Evogene Ltd (NASDAQ: EVGN ) (announced $10 million equity investment led by ARK Investment Management) I-Mab ADR (NASDAQ: IMAB ) Immunomedics, Inc. (NASDAQ: IMMU ) Intuitive Surgical, Inc. (NASDAQ: ISRG ) Pacific Biosciences of California Inc (NASDAQ: PACB ) PPD Inc (NASDAQ: PPD ) Shockwave Medical Inc (NASDAQ: SWAV ) Tandem Diabetes Care Inc (NASDAQ: TNDM ) TG Therapeutics Inc common stock (NASDAQ: TGTX ) Twist Bioscience Corp (NASDAQ: TWST ) West Pharmaceutical Services Inc. (NYSE: WST ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Sept. 1) Acasti Pharma Inc (NASDAQ: ACST ) ADiTx Therapeutics Inc (NASDAQ: ADTX ) China SXT Pharmaceuticals Inc (NASDAQ: SXTC ) Entera Bio Ltd (NASDAQ: ENTX ) Freeline Therapeutics Holdings PLC (NASDAQ: FRLN ) Happiness Biotech Group Ltd (NASDAQ: HAPP ) Histogen Inc (NASDAQ: HSTO ) Immatics NV (NASDAQ: IMTX ) NanoVibronix Inc (NASDAQ: NAOV ) Oncternal Therapeutics Inc (NASDAQ: ONCT ) Predictive Oncology Inc (NASDAQ: POAI ) Rockwell Medical Inc (NASDAQ: RMTI ) Sun BioPharma, Inc. (NASDAQ: SNBP ) Stocks In Focus Mesoblast Gets Ethics Approval For Using Stem Cell Therapy In COVID-19 Patients In Australia Mesoblast (NASDAQ: MESO ) said it has received ethics approval to include Australian hospitals in the Phase 3 randomized controlled trial of remestemcel-L in ventilator-dependent COVID-19 patients with acute respiratory distress syndrome.
   Tandem Diabetes Care Announces Second Quarter 2020 Financial Results and Full Year 2020 Sales Guidance  2020/07/30 20:05:00 Business Wire
SAN DIEGO--(BUSINESS WIRE)---- $TNDM #ControlIQ--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today reported its financial results for the quarter ended June 30, 2020. In addition, the Company provided sales guidance for the year ending December 31, 2020. “We achieved our highest quarterly sales, successfully completed our first acquisition, and executed multiple meaningful agreements in support of our longer-term objectives in the second quarter,” said John
   Tandem Diabetes Care Appoints Peyton Howell to Board of Directors  2020/07/29 20:05:00 Business Wire
SAN DIEGO--(BUSINESS WIRE)---- $TNDM--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the appointment of Peyton Howell as an independent member of its board of directors effective August 3, 2020. Ms. Howell brings to the Tandem board extensive reimbursement, health insurance, and patient access experience across a broad range of disease states in the hospital, physician, pharmacy and home care settings. “Peyton brings significant expe
   BRIEF-Medtronic And Tandem Diabetes Care Enter Into Patent Cross-License Agreement  2020/07/09 13:18:29 Reuters
Tandem Diabetes Care Inc:
   JDRF and Tandem Diabetes Care Partner to Help Educate and Support the T1D Community  2020/07/08 13:00:00 Business Wire
SAN DIEGO--(BUSINESS WIRE)-- #T1D--JDRF and Tandem Diabetes Care partner to help educate and support the T1D community.
   Tandem Diabetes Care to Announce Second Quarter 2020 Financial Results on July 30, 2020  2020/07/07 20:05:00 Business Wire
SAN DIEGO--(BUSINESS WIRE)---- $TNDM--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its second quarter 2020 results after the financial markets close on Thursday, July 30, 2020. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its second quarter 2020 financial and operating results. Conference Call/Webcast Details: Date: July 30, 2020 Time: 4
   The Daily Biotech Pulse: Novartis Settles Lawsuit For $678M, Sarepta In-Licenses Gene Therapy Pre-Treatment, Unity Biotech Outlines Second-Half Catalysts  2020/07/02 12:21:23 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 1) AbbVie Inc (NYSE: ABBV ) ADC Therapeutics SA (NYSE: ADCT ) Affimed NV (NASDAQ: AFMD ) Agios Pharmaceuticals Inc (NASDAQ: AGIO ) Akero Therapeutics Inc (NASDAQ: AKRO ) ( announced positive results for mid-stage study of NASH drug) Amgen, Inc. (NASDAQ: AMGN ) (reacted to a favorable court ruling on its Enbrel patent litigation) Aptinyx Inc (NASDAQ: APTX ) BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ) Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP ) Crispr Therapeutics AG (NASDAQ: CRSP ) Halozyme Therapeutics, Inc. (NASDAQ: HALO ) Hologic, Inc. (NASDAQ: HOLX ) Legend Biotech Corp (NASDAQ: LEGN ) Liminal BioSciences Inc (NASDAQ: LMNL ) (announced commencement of convalescent plasma collection from donors who have recovered from COVID-19 and upcoming catalysts) Natera Inc (NASDAQ: NTRA ) Opko Health Inc. (NASDAQ: OPK ) Pacira Biosciences Inc (NASDAQ: PCRX ) Tandem Diabetes Care Inc (NASDAQ: TNDM ) Twist Bioscience Corp (NASDAQ: TWST ) Ultragenyx Pharmaceutical Inc (NASDAQ: RARE ) (announced FDA approval for drug to treat long-chain fatty acid oxidation disorders) Down In The Dumps (Biotech Stocks Hitting 52-week Lows July 1) ADiTx Therapeutics Inc (NASDAQ: ADTX ) Fusion Pharmaceuticals Inc (NASDAQ: FUSN ) Generation Bio Co (NASDAQ: GBIO ) Hoth Therapeutics Inc (NASDAQ: HOTH ) Iterum Therapeutics PLC (NASDAQ: ITRM ) Repare Therapeutics Inc (NASDAQ: RPTX ) Stocks In Focus Novartis Finalizes $678M Settlement In US Lawsuit Over Kickbacks Paid To Doctors Novartis AG (NYSE: NVS ) said it has finalized its previously disclosed agreement with the U.S.
   The Daily Biotech Pulse: T2 Biosystems Launches COVID-19 Test, Akero Aces Midstage NASH Study, Aravive Added to Russell Indexes  2020/07/01 12:12:04 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 30) ADC Therapeutics SA (NYSE: ADCT ) Akebia Therapeutics Inc (NASDAQ: AKBA ) Alterity Therapeutics Ltd (NASDAQ: ATHE ) ( announced agreement with the FDA regarding Phase 2 study of Parkinsonian disorder drug) Calliditas Therapeutics AB ADR (NASDAQ: CALT ) GENMAB A/S/S ADR (NASDAQ: GMAB ) - partner Seattle Genetics, Inc. (NASDAQ: SGEN ) announced positive results for antibody-drug conjugate for cervical cancer Halozyme Therapeutics, Inc. (NASDAQ: HALO ) Hologic, Inc. (NASDAQ: HOLX ) ( reacted to a positive analyst action) Legend Biotech Corp (NASDAQ: LEGN ) Meridian Bioscience, Inc. (NASDAQ: VIVO ) Mersana Therapeutics Inc (NASDAQ: MRSN ) Novavax, Inc. (NASDAQ: NVAX ) Opko Health Inc. (NASDAQ: OPK ) Pacira Biosciences Inc (NASDAQ: PCRX ) Pliant Therapeutics Inc (NASDAQ: PLRX ) ResMed Inc. (NYSE: RMD ) Tandem Diabetes Care Inc (NASDAQ: TNDM ) Twist Bioscience Corp (NASDAQ: TWST ) (announced launch of Twist Respiratory Virus Research Panel for detecting a range of respiratory diseases) West Pharmaceutical Services Inc. (NYSE: WST ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows June 30) Brickell Biotech Inc (NASDAQ: BBI ) Iterum Therapeutics PLC (NASDAQ: ITRM ) (announced $15 million registered offering) Qualigen Therapeutics Inc (NASDAQ: QLGN ) Sonnet Biotherapeutics Holdings Inc (NASDAQ: SONN ) VIVUS, Inc. (NASDAQ: VVUS ) Stocks In Focus T2 Biosystems Pre-Announces In-Line Q2 Revenues, Launches COVID-19 Test In US T2 Biosystems Inc (NASDAQ: TTOO ) announced the U.S. launch of the T2SARS-CoV-2 Panel, its COVID-19 molecular diagnostic test.

 関連キーワード  (医療機器_医療用品_ディストリビュ―タ― 米国株 タンデム・ダイアベティス・ケア TNDM Tandem Diabetes Care Inc.)

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)